Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center

被引:129
作者
Valentín-Gamazo, C
Malagó, M
Karliova, M
Lutz, JT
Frilling, A
Nadalin, S
Testa, G
Ruehm, SG
Erim, Y
Paul, A
Lang, H
Gerken, G
Broelsch, CE
机构
[1] Univ Hosp Essen, Dept Gen Surg & Transplantat, D-45122 Essen, Germany
[2] Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany
[3] Univ Hosp Essen, Dept Anesthesiol & Crit Care Med, D-45122 Essen, Germany
[4] Univ Hosp Essen, Dept Psychotherapy & Psychosomat, D-45122 Essen, Germany
[5] Univ Hosp Essen, Inst Diagnost & Intervent Radiol, D-45122 Essen, Germany
[6] Univ Illinois, Dept Surg, Div Transplantat, Chicago, IL USA
关键词
D O I
10.1002/lt.20223
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Adequate selection of donors is a major prerequisite for living donor liver transplantation (LDLT). Few centers report on the entire number of potential donors considered or rejected for living donation. From April 1998 to July 2003, a total of 111 living donor liver transplantations were performed at our institution, with 622 potential donors for 297 adult recipients and 78 potential donors for 52 pediatric recipients evaluated. In the adult group, only 89 (14%) potential donors were considered suitable, with a total of 533 (86%) potential donors rejected. Of these, 67% were excluded either at initial screening or during the first and second steps of the evaluation procedure. In 31% of all cases, the evaluation of donors was canceled because of recipient issues. In the pediatric group, 22 (28%) donors were selected, with the other 56 (72%) rejected. Costs of the complete evaluation process accounted for 4,589 Euro (C) per donor. The evaluation of a potential living donor is a complex and expensive process. We present the results on the evaluation of the largest group of potential donors for adults reported in the literature. Only 14% of potential donors in our series were considered suitable candidates. It has not yet been established who should cover the expenses of the evaluation of all rejected donors. In conclusion, all efforts should be made in order to develop an effective screening protocol for the evaluation of donors with the aim of saving time and resources for a liver transplantation program.
引用
收藏
页码:1087 / 1096
页数:10
相关论文
共 30 条
[1]   Emergency Adult to Adult Living Donor Liver Transplantation for fulminant hepatic failure - Is it justifiable? [J].
Abouna, GJM .
TRANSPLANTATION, 2001, 71 (10) :1498-1499
[2]   Assessment of potential donors for living related liver transplantation [J].
Baker, A ;
Dhawan, A ;
Devlin, J ;
Mieli-Vergani, G ;
O'Grady, J ;
Williams, R ;
Rela, M ;
Heaton, N .
BRITISH JOURNAL OF SURGERY, 1999, 86 (02) :200-205
[3]   Evaluation of the donor liver for living donor liver transplantation [J].
Brandhagen, D ;
Fidler, J ;
Rosen, C .
LIVER TRANSPLANTATION, 2003, 9 (10) :S16-S28
[4]   A survey of liver transplantation from living adult donors in the United States [J].
Brown, RS ;
Russo, MW ;
Lai, M ;
Shiffman, ML ;
Richardson, MC ;
Everhart, JE ;
Hoofnagle, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :818-825
[5]   Proceed with caution: Live living donation of lobes of liver for transplantation [J].
Caplan, AL .
LIVER TRANSPLANTATION, 2001, 7 (06) :494-495
[6]   Evaluation of living liver donors [J].
Chen, YS ;
Cheng, YF ;
de Villa, VH ;
Wang, CC ;
Lin, CC ;
Huang, TL ;
Jawan, B ;
Chen, CL .
TRANSPLANTATION, 2003, 75 (03) :S16-S19
[7]   Guidelines for the psychosomatic evaluation of living liver donors:: Analysis of donor exclusion [J].
Erim, Y ;
Malagó, M ;
Valentin-Gamazo, C ;
Senf, W ;
Broelsch, CE .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) :909-910
[8]   Donor selection for living-related liver transplantation [J].
Hashikura, Y ;
Kawasaki, S ;
Miyagawa, S ;
Terada, M ;
Ikegami, T ;
Nakazawa, Y ;
Miwa, S ;
Chisuwa, H ;
Kubota, T .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (08) :3410-3411
[9]  
Hashikura Y, 2002, WORLD J SURG, V26, P243
[10]   Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin [J].
Karliova, M ;
Malago, M ;
Trippler, M ;
Valentin-Gamazo, C ;
Rothaar, T ;
Broelsch, CE ;
Gerken, G ;
Treichel, U .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (08) :3319-3322